Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4598)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He SL, Shen J, Sun XJ, Zhu XJ, Liu LM, Dong JC. Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments. World J Gastroenterol 2013; 19(28): 4552-4558 [PMID: 23901232 DOI: 10.3748/wjg.v19.i28.4552] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i28/4552.htm |
| Number | Citing Articles |
| 1 |
F. Petrelli, A. Coinu, K. Borgonovo, M. Cabiddu, M. Ghilardi, V. Lonati, S. Barni. Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis. Clinical Oncology 2014; 26(8): 488 doi: 10.1016/j.clon.2014.04.031
|
| 2 |
Robert Goldstein, Dominic Yu, Roopinder Gillmore, Christina Thirlwell, Pam O'Donoghue, Astrid Mayer, Tim Meyer. Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: case report and single-center retrospective review. Future Oncology 2014; 10(13): 2007 doi: 10.2217/fon.14.108
|
| 3 |
Matteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, Vanessa De Pace, Flavia Neri, Maria Aurelia Barbera, Lorenzo Maroni, Giorgio Frega, Andrea Palloni, Stefania De Lorenzo, Maria Cristina Ripoli, Maria Abbondanza Pantaleo, Matteo Cescon, Massimo Del Gaudio, Giovanni Brandi. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11810-z
|
| 4 |
Filippo Pelizzaro, Ambra Sammarco, Vincenzo Dadduzio, Davide Pastorelli, Petros Giovanis, Caterina Soldà, Mario Domenico Rizzato, Giuseppe Lombardi, Sara Lonardi, Giulia Peserico, Angela Imondi, Anna Sartori, Gemma Maddalo, Fabio Farinati. Capecitabine in advanced hepatocellular carcinoma: A multicenter experience. Digestive and Liver Disease 2019; 51(12): 1713 doi: 10.1016/j.dld.2019.06.015
|
| 5 |
Lin Liu, Ying-hui Zheng, Li Han, Shu-Kui Qin. Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma. Medicine 2016; 95(40): e4993 doi: 10.1097/MD.0000000000004993
|
| 6 |
Gui-Nan Lin, Xiao-Mei Jiang, Jie-Wen Peng, Jian-Jun Xiao, Dong-Ying Liu, Zhong-Jun Xia. Prognostic Significance of the Peripheral Blood Absolute Monocyte Count in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma Receiving Systemic Chemotherapy. Asian Pacific Journal of Cancer Prevention 2014; 15(15): 6387 doi: 10.7314/APJCP.2014.15.15.6387
|
| 7 |
Shukui Qin, Xinlei Gong. Progression of systemic chemotherapy with oxaliplatin-containing regimens for advanced hepatocellular carcinoma in China. Hepatic Oncology 2016; 3(1): 71 doi: 10.2217/hep.15.42
|
| 8 |
Franco Trevisani, Giovanni Brandi, Francesca Garuti, Maria Aurelia Barbera, Raffaella Tortora, Andrea Casadei Gardini, Alessandro Granito, Francesco Tovoli, Stefania De Lorenzo, Andrea Lorenzo Inghilesi, Francesco Giuseppe Foschi, Mauro Bernardi, Fabio Marra, Rodolfo Sacco, Giovan Giuseppe Di Costanzo. Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. Journal of Cancer Research and Clinical Oncology 2018; 144(2): 403 doi: 10.1007/s00432-017-2556-6
|
| 9 |
Songporn Oranratnachai, Sasivimol Rattanasiri, Ekaphop Sirachainan, Amarit Tansawet, Nilubol Raunroadroong, Gareth J. McKay, John Attia, Ammarin Thakkinstian. Treatment outcomes of advanced hepatocellular carcinoma in real‐life practice: Chemotherapy versus multikinase inhibitors. Cancer Medicine 2023; 12(3): 3046 doi: 10.1002/cam4.5224
|
| 10 |
Changjiang Lei, Defa Ren, Meixia Fu, Chuantao Sun, Hong Ren, Qingyun Pan, Yuan Li. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10022
|